Publications 2022

Langberg NE, Jenssen TG, Haugen AJ, Mjoen G, Birkeland KI, Asberg A, Hartmann A, Dahle DO (2022)
Endothelial Dysfunction and 6-Year Risk of Mortality in Kidney Transplant Recipients
Transplant. Direct., 8 (1), e1262
DOI 10.1097/TXD.0000000000001262

Publications 2021

Jorgensen HS, Eide IA, Jenssen T, Asberg A, Bollerslev J, Godang K, Hartmann A, Schmidt EB, Svensson M (2021)
Marine n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Kidney Transplant Recipients: A Randomized, Placebo-Controlled Trial
Nutrients, 13 (7), 2361
DOI 10.3390/nu13072361

Witczak BJ, Pischke SE, Reisaeter AV, Midtvedt K, Ludviksen JK, Heldal K, Jenssen T, Hartmann A, Asberg A, Mollnes TE (2021)
Elevated Terminal C5b-9 Complement Complex 10 Weeks Post Kidney Transplantation Was Associated With Reduced Long-Term Patient and Kidney Graft Survival
Front. Immunol., 12, 738927
DOI 10.3389/fimmu.2021.738927

Publications 2020

Asberg A, Bjerre A, Almaas R, Luis-Lima S, Robertsen I, Salvador CL, Porrini E, Schwartz GJ, Hartmann A, Bergan S (2020)
Measured GFR by Utilizing Population Pharmacokinetic Methods to Determine Iohexol Clearance
Kidney Int. Rep., 5 (2), 189-198
DOI 10.1016/j.ekir.2019.11.012

Hartmann A, Abel S (2020)
How Oslo Achieved Zero Pedestrian and Bicycle Fatalities in 2019, and How Other Cities Can Apply What Worked
ITE J.-Inst. Transp. Eng., 90 (5), 32-38

Haugen AJ, Hallan S, Langberg NE, Dahle DO, Pihlstrom H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjoen G (2020)
Increased long-term risk for hypertension in kidney donors - a retrospective cohort study
Transpl. Int., 33 (5), 536-543
DOI 10.1111/tri.13576

Nordheim E, Dahle DO, Halden T, Birkeland KI, Asberg A, Hartmann A, Horneland R, Jenssen TG (2020)
Endothelial function after pancreas transplantation-A single-center observational study
Clin. Transplant., 34 (3), e13815
DOI 10.1111/ctr.13815

Pihlstrom HK, Ueland T, Michelsen AE, Aukrust P, Gatti F, Hammarstrom C, Kasprzycka M, Wang JB, Haraldsen G, Mjoen G, Dahle DO, Midtvedt K, Eide IA, Hartmann A, Holdaas H (2020)
Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients
PLoS One, 15 (12), e0243759
DOI 10.1371/journal.pone.0243759

Publications 2019

Chandra A, Svensson M, Asberg A, Schmidt EB, Bjerve KS, Jenssen T, Hartmann A, Ueland T, Eide IA (2019)
Trans-fatty Acids and Survival in Renal Transplantation
J. Renal Nutr., 29 (3), 169-180
DOI 10.1053/j.jrn.2018.08.003

Egeland EJ, Reisaeter AV, Robertsen I, Midtvedt K, Strom EH, Holdaas H, Hartmann A, Asberg A (2019)
High tacrolimus clearance - a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single-center cohort study
Transpl. Int., 32 (3), 257-269
DOI 10.1111/tri.13356

Eide IA, Reinholt FP, Jenssen T, Hartmann A, Schmidt EB, Asberg A, Bergan S, Brabrand K, Syensson M (2019)
Effects of marine n-3 fatty acid supplementation in renal transplantation: A randomized controlled trial
Am. J. Transplant., 19 (3), 790-800
DOI 10.1111/ajt.15080

Gustavsen MT, Midtvedt K, Lonning K, Jacobsen T, Reisaeter AV, De Geest S, Andersen MH, Hartmann A, Asberg A (2019)
Evaluation of tools for annual capture of adherence to immunosuppressive medications after renal transplantation - a single-centre open prospective trial
Transpl. Int., 32 (6), 614-625
DOI 10.1111/tri.13412

Halden TAS, Kvitne KE, Midtvedt K, Rajakumar L, Robertsen I, Brox J, Bollerslev J, Hartmann A, Asberg A, Jenssen T (2019)
Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus
Diabetes Care, 42 (6), 1067-1074
DOI 10.2337/dc19-0093

Haugen AJ, Langberg NE, Dahle DO, Pihlstrom H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjoen G (2019)
Long-term risk for kidney donors with hypertension at donation - a retrospective cohort study
Transpl. Int., 32 (9), 960-964
DOI 10.1111/tri.13443

Jenssen T, Hartmann A (2019)
Post-transplant diabetes mellitus in patients with solid organ transplants
Nat. Rev. Endocrinol., 15 (3), 172-188
DOI 10.1038/s41574-018-0137-7

Mjoen G, Reisaeter A, Hartmann A, Dahle DO, Holdaas H (2019)
Regarding age-calibrated glomerular filtration rate
Kidney Int., 95 (1), 234-235
DOI 10.1016/j.kint.2018.10.003

Thorsen IS, Bleskestad IH, Asberg A, Hartmann A, Skadberg O, Brede C, Ueland T, Pasch A, Reisaeter AV, Goransson LG (2019)
Vitamin D as a risk factor for patient survival after kidney transplantation: A prospective observational cohort study
Clin. Transplant., 33 (5), e13517
DOI 10.1111/ctr.13517

Ussif AM, Asberg A, Halden TAS, Nordheim E, Hartmann A, Jenssen T (2019)
Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation
BMC Nephrol., 20, 12
DOI 10.1186/s12882-018-1171-3

Publications 2018

Egeland EJ, Storset E, Robertsen I, Hermann M, Midtvedt K, Gustavsen MT, Klaasen R, Bergan S, Hartmann A, Asberg A (2018)
The Authors' Reply
Transplantation, 102 (1), e43-e44
DOI 10.1097/TP.0000000000001961

Eide IA, Dorje C, Svensson M, Jenssen T, Hammarstrom C, Scott H, Bjerve KS, Christensen JH, Schmidt EB, Hartmann A, Asberg A, Reisaeter AV, Reinholt FP (2018)
Development of Kidney Transplant Fibrosis Is Inversely Associated With Plasma Marine Fatty Acid Level
J. Renal Nutr., 28 (2), 118-124
DOI 10.1053/j.jrn.2017.09.001

Heldal K, Midtvedt K, Hartmann A, Reisaeter AV, Heldal TF, Bergan S, Salvador CL, Asberg A (2018)
Estimated glomerular filtration rate in stable older kidney transplant recipients-are present algorithms valid? A national cross-sectional cohort study
Transpl. Int., 31 (6), 629-638
DOI 10.1111/tri.13137

Heldal TF, Ueland T, Jenssen T, Hartmann A, Reisaeter AV, Aukrust P, Michelsen A, Asberg A (2018)
Inflammatory and related biomarkers are associated with post-transplant diabetes mellitus in kidney recipients: a retrospective study
Transpl. Int., 31 (5), 510-519
DOI 10.1111/tri.13116

Jardine AG, Hartmann A, Holdaas H (2018)
Long-term renal allograft survival: a quiet revolution
Kidney Int., 94 (5), 853-855
DOI 10.1016/j.kint.2018.08.005

Lonning K, Heldal K, Bernklev T, Brunborg C, Andersen MH, von der Lippe N, Reisaeter AV, Line PD, Hartmann A, Midtvedt K (2018)
Improved Health-Related Quality of Life in Older Kidney Recipients 1 Year After Transplantation
Transplant. Direct., 4 (4), e351
DOI 10.1097/TXD.0000000000000770

Lonning K, Midtvedt K, Bernklev T, Brunborg C, Andersen MH, von der Lippe N, Reisaeter AV, Line PD, Hartmann A, Heldal K (2018)
Changes in health-related quality of life in older candidates waiting for kidney transplantation
Nephrology, 23 (10), 948-956
DOI 10.1111/nep.13117

Nordheim E, Birkeland KI, Asberg A, Hartmann A, Horneland R, Jenssen T (2018)
Preserved insulin secretion and kidney function in recipients with functional pancreas grafts 1 year after transplantation: a single-center prospective observational study
Eur. J. Endocrinol., 179 (4), 251-259
DOI 10.1503/EJE-18-0360

Skaare H, Svensson M, Jenssen T, Asberg A, Schmidt EB, Chandra A, Ueland T, Mollnes TE, Hartmann A, Eide IA (2018)
Plasma n-6 Polyunsaturated Fatty Acid Levels and Survival in Renal Transplantation
J. Renal Nutr., 28 (5), 333-339
DOI 10.1053/j.jrn.2018.02.008

Ussif A, Pihlstrom H, Pasch A, Holdaas H, Hartmann A, Smerud K, Asberg A (2018)
Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score
BMC Nephrol., 19, 212
DOI 10.1186/s12882-018-1000-8

von During ME, Jenssen T, Bollerslev J, Godang K, Hartmann A, Asberg A (2018)
Arterial stiffness is associated with visceral fat mass in kidney transplanted patients-A nationwide cohort study
Clin. Transplant., 32 (8), e13341
DOI 10.1111/ctr.13341

Publications 2017

Dahle DO, Grotmol T, Leivestad T, Hartmann A, Midtvedt K, Reisaeter AV, Mjoen G, Pihlstrom HK, Naess H, Holdaas H (2017)
Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients
Transplantation, 101 (10), 2599-2605
DOI 10.1097/TP.0000000000001659

Dupont L, Eide IA, Hartmann A, Christensen JH, Asberg A, Jenssen T, Krarup H, Svensson M (2017)
Haptoglobin 2-2 Genotype, Patient, and Graft Survival in Renal Transplant Recipients
Prog. Transplant., 27 (4), 386-391
DOI 10.1177/1526924817732020

Egeland EJ, Robertsen I, Hermann M, Midtvedt K, Storset E, Gustavsen MT, Reisaeter AV, Klaasen R, Bergan S, Holdaas H, Hartmann A, Asberg A (2017)
High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation
Transplantation, 101 (8), E273-E279
DOI 10.1097/TP.0000000000001796

Eide IA, Asberg A, Svensson M, Ueland T, Mollnes TE, Hartmann A, Bjerve KS, Michelsen A, Aukrust P, Christensen JH, Schmidt EB, Jenssen T (2017)
Plasma Levels of Marine n-3 Fatty Acids Are Inversely Correlated With Proinflammatory Markers sTNFR1 and IL-6 in Renal Transplant Recipients
J. Renal Nutr., 27 (3), 161-168
DOI 10.1053/j.jrn.2016.09.008

Eide IA, Halden TAS, Hartmann A, Dahle DO, Asberg A, Jenssen T (2017)
Associations Between Posttransplantation Diabetes Mellitus and Renal Graft Survival
Transplantation, 101 (6), 1282-1289
DOI 10.1097/TP.0000000000001259

Heldal K, Hartmann A, Lonning K, Leivestad T, Reisaeter AV, Line PD, Holdaas H, Midtvedt K (2017)
Should patients older than 65 years be offered a second kidney transplant?
BMC Nephrol., 18, 13
DOI 10.1186/s12882-016-0426-0

Jenssen T, Hartmann A, Birkeland RI (2017)
Long-term diabetes complications after pancreas transplantation
Curr. Opin. Organ Transpl., 22 (4), 382-388
DOI 10.1097/MOT.0000000000000436

Lindahl JP, Massey RJ, Hartmann A, Aakhus S, Endresen K, Gunther A, Midtvedt K, Holdaas H, Leivestad T, Horneland R, Oyen O, Jenssen T (2017)
Cardiac Assessment of Patients With Type 1 Diabetes Median 10 Years After Successful Simultaneous Pancreas and Kidney Transplantation Compared With Living Donor Kidney Transplantation
Transplantation, 101 (6), 1261-1267
DOI 10.1097/TP.0000000000001274

Meyer KB, Hartmann A, Mjoen G, Andersen MH (2017)
Relationships Between Clinical, Self-Reported, and Donation Specific Outcomes: A Prospective Follow-up Study 10 Years After Kidney Donation
Ann. Transpl., 22, 148-155
DOI 10.12659/AOT.902330

Pihlstrom HK, Gatti F, Hammarstrom C, Eide IA, Kasprzycka M, Wang JB, Haraldsen G, Svensson MHS, Midtvedt K, Mjoen G, Dahle DO, Hartmann A, Holdaas H (2017)
Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study
Transpl. Int., 30 (8), 827-840
DOI 10.1111/tri.12973

Rose J, Emery VC, Kumar D, Asberg A, Hartmann A, Jardine AG, Bignamini AA, Humar A, Neumann AU (2017)
Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection
PLoS Pathog., 13 (4), e1006299
DOI 10.1371/journal.ppat.1006299

Salvador CL, Hartmann A, Asberg A, Bergan S, Rowe AD, Morkrid L (2017)
Estimating Glomerular Filtration Rate in Kidney Transplant Recipients: Comparing a Novel Equation With Commonly Used Equations in this Population
Transplant. Direct., 3 (12), e332
DOI 10.1097/TXD.0000000000000742

Smerud KT, Asberg A, Kile H, Pasch A, Dahle DO, Bollerslev J, Godang K, Hartmann A (2017)
A rapid and sustained improvement of calcification propensity score (serum T-50) after successful kidney transplantation: Reanalysis of a randomized controlled trial of ibandronate
Clin. Transplant., 31 (12), e13131
DOI 10.1111/ctr.13131

von During ME, Jenssen T, Bollerslev J, Asberg A, Godang K, Hartmann A (2017)
Visceral fat is strongly associated with post-transplant diabetes mellitus and glucose metabolism 1year after kidney transplantation
Clin. Transplant., 31 (1), e12869
DOI 10.1111/ctr.12869

Publications 2016

Asberg A, Humar A, Rollag H, Jardine AG, Kumar D, Aukrust P, Ueland T, Bignamini AA, Hartmann A (2016)
Lessons Learned From a Randomized Study of Oral Valganciclovir Versus Parenteral Ganciclovir Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: The VICTOR Trial
Clin. Infect. Dis., 62 (9), 1154-1160
DOI 10.1093/cid/ciw084

Dorje C, Reisaeter AV, Dahle DO, Mjoen G, Midtvedt K, Holdaas H, Flaa-Johnsen L, Syversveen T, Hartmann A, Jenssen T, Scott H, Reinholt FP (2016)
Total inflammation in early protocol kidney graft biopsies does not predict progression of fibrosis at one year post-transplant
Clin. Transplant., 30 (7), 802-809
DOI 10.1111/ctr.12753

Eide IA, Halden TAS, Hartmann A, Asberg A, Dahle DO, Reisaeter AV, Jenssen T (2016)
Mortality risk in post-transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteria
Transpl. Int., 29 (5), 568-578
DOI 10.1111/tri.12757

Eide IA, Jenssen T, Hartmann A, Diep LM, Dahle DO, Reisaeter AV, Bjerve KS, Christensen JH, Schmidt EB, Svensson M (2016)
Plasma levels of marine n-3 polyunsaturated fatty acids and renal allograft survival
Nephrol. Dial. Transplant., 31 (1), 160-167
DOI 10.1093/ndt/gfv339

Halden TAS, Egeland EJ, Asberg A, Hartmann A, Midtvedt K, Khiabani HZ, Holst JJ, Knop FK, Hornum M, Feldt-Rasmussen B, Jenssen T (2016)
GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation Diabetes
Diabetes Care, 39 (4), 617-624
DOI 10.2337/dc15-2383

Jorgensen HS, Eide IA, Hartmann A, Asberg A, Christensen JH, Schmidt EB, Godang K, Bollerslev J, Svensson M (2016)
Plasma n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Renal Transplant Recipients
J. Renal Nutr., 26 (3), 196-203
DOI 10.1053/j.jrn.2015.11.007

Lindahl JP, Hartmann A, Aakhus S, Endresen K, Midtvedt K, Holdaas H, Leivestad T, Horneland R, Yen O, Jenssen T (2016)
Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantation
Diabetologia, 59 (4), 844-852
DOI 10.1007/s00125-015-3853-8

Lonning K, Midtvedt K, Leivestad T, Reisaeter AV, Line PD, Hartmann A, Heldal K (2016)
Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?
Transplantation, 100 (12), 2705-2709
DOI 10.1097/TP.0000000000001363

Meyer K, Wahl AK, Bjork IT, Wisloff T, Hartmann A, Andersen MH (2016)
Long-term, self-reported health outcomes in kidney donors
BMC Nephrol., 17, 8
DOI 10.1186/s12882-016-0221-y

Nordheim E, Dahle DO, Syse IM, Asberg A, Reisaeter AV, Hartmann A (2016)
Resolution of Calciphylaxis After Urgent Kidney Transplantation in 3 Patients With End-Stage Kidney Failure
Transplant. Direct., 2 (11), e113
DOI 10.1097/TXD.0000000000000627

Smedbraten J, Mjoen G, Hartmann A, Asberg A, Rollag H, Mollnes TE, Sandvik L, Fagerland MW, Thiel S, Sagedal S (2016)
Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients
BMC Nephrol., 17, 148
DOI 10.1186/s12882-016-0373-9

Storset E, Asberg A, Hartmann A, Reisaeter AV, Holdaas H, Skauby M, Bergan S, Midtvedt K (2016)
Low-target tacrolimus in de novo standard risk renal transplant recipients: A single-centre experience
Nephrology, 21 (10), 821-827
DOI 10.1111/nep.12738

Publications 2015

Aulie HA, Selvaag AM, Gunther A, Lilleby V, Molberg O, Hartmann A, Holdaas H, Flato B (2015)
Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritis
Ann. Rheum. Dis., 74 (8), 1515-1521
DOI 10.1136/annrheumdis-2013-204804

Dahle DO, Eide IA, Asberg A, Leivestad T, Holdaas H, Jenssen TG, Fagerland MW, Pihlstrom H, Mjoen G, Hartmann A (2015)
Aortic Stiffness in a Mortality Risk Calculator for Kidney Transplant Recipients
Transplantation, 99 (8), 1730-1737
DOI 10.1097/TP.0000000000000660

Eide IA, Halden TAS, Hartmann A, Asberg A, Dahle DO, Reisaeter AV, Jenssen T (2015)
Limitations of Hemoglobin A1c for the Diagnosis of Posttransplant Diabetes Mellitus
Transplantation, 99 (3), 629-635
DOI 10.1097/TP.0000000000000376

Eide IA, Jenssen T, Hartmann A, Diep LM, Dahle DO, Reisaeter AV, Bjerve KS, Christensen JH, Schmidt EB, Svensson M (2015)
The Association between Marine n-3 Polyunsaturated Fatty Acid Levels and Survival after Renal Transplantation
Clin. J. Am. Soc. Nephrol., 10 (7), 1246-1256
DOI 10.2215/CJN.11931214

Jenssen T, Hartmann A (2015)
Emerging treatments for post-transplantation diabetes mellitus
Nat. Rev. Nephrol., 11 (8), 465-477
DOI 10.1038/nrneph.2015.59

Reine TM, Kolseth IBM, Meen AJ, Lindahl JP, Jenssen TG, Reinholt FP, Zaia J, Shao C, Hartmann A, Kolset SO (2015)
Effects of restoring normoglycemia in type 1 diabetes on inflammatory profile and renal extracellular matrix structure after simultaneous pancreas and kidney transplantation
Diabetes Res. Clin. Pract., 107 (1), 46-53
DOI 10.1016/j.diabres.2014.10.006

Smedbraten YV, Sagedal S, Mjoen G, Hartmann A, Fagerland MW, Rollag H, Mollnes TE, Thiel S (2015)
High Ficolin-3 Level at the Time of Transplantation Is an Independent Risk Factor for Graft Loss in Kidney Transplant Recipients
Transplantation, 99 (4), 791-796
DOI 10.1097/TP.0000000000000422

Ueland T, Rollag H, Hartmann A, Jardine A, Humar A, Bignamini AA, Asberg A, Aukrust P (2015)
Increased Osteoprotegerin Predicts Poor Virological Outcome During Anticytomegalovirus Therapy in Solid Organ Transplant Recipients
Transplantation, 99 (1), 100-105
DOI 10.1097/TP.0000000000000227

von During ME, Jenssen T, Bollerslev J, Asberg A, Godang K, Eide IA, Dahle DO, Hartmann A (2015)
Visceral fat is better related to impaired glucose metabolism than body mass index after kidney transplantation
Transpl. Int., 28 (10), 1162-1171
DOI 10.1111/tri.12606

Publications 2014

Bleskestad IH, Bergrem H, Leivestad T, Hartmann A, Goransson LG (2014)
Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function
Clin. Transplant., 28 (4), 479-486
DOI 10.1111/ctr.12341

Chen ZG, Bouamar R, Van Schaik RHN, De Fijter JW, Hartmann A, Zeier M, Budde K, Kuypers DRJ, Weimar W, Hesselink DA, Van Gelder T (2014)
Genetic polymorphisms in IL-2, IL-10, TGF-beta 1, and IL-2RB and acute rejection in renal transplant patients
Clin. Transplant., 28 (6), 649-655
DOI 10.1111/ctr.12346

Dahle DO, Jenssen T, Holdaas H, Asberg A, Soveri I, Holme I, Mjoen G, Eide IA, Pihlstrom H, Doerje C, Halden TAS, Hartmann A (2014)
Uric acid and clinical correlates of endothelial function in kidney transplant recipients
Clin. Transplant., 28 (10), 1167-1176
DOI 10.1111/ctr.12435

Dahle DO, Jenssen T, Holdaas H, Leivestad T, Vardal M, Mjoen G, Reisaeter AV, Toft I, Hartmann A (2014)
Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients
Clin. Transplant., 28 (1), 134-140
DOI 10.1111/ctr.12290

Halden TAS, Asberg A, Vik K, Hartmann A, Jenssen T (2014)
Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation
Nephrol. Dial. Transplant., 29 (4), 926-933
DOI 10.1093/ndt/gft536

Lindahl JP, Jenssen T, Hartmann A (2014)
Long-term outcomes after organ transplantation in diabetic end-stage renal disease
Diabetes Res. Clin. Pract., 105 (1), 14-21
DOI 10.1016/j.diabres.2014.03.004

Lindahl JP, Reinholt FP, Eide IA, Hartmann A, Midtvedt K, Holdaas H, Dorg LT, Reine TM, Kolset SO, Horneland R, Oyen O, Brabrand K, Jenssen T (2014)
In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone
Diabetologia, 57 (11), 2357-2365
DOI 10.1007/s00125-014-3353-2

Mjoen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Oyen O, Reisaeter A, Pfeffer P, Jenssen T, Leivestad T, Line PD, Ovrehus M, Dale DO, PihIstrom H, Holme I, Dekker FW, Holdaas H (2014)
Long-term risks for kidney donors
Kidney Int., 86 (1), 162-167
DOI 10.1038/ki.2013.460

Smedbraten YV, Sagedal S, Leivestad T, Mjoen G, Osnes K, Rollag H, Reisaeter AV, Foss A, Os I, Hartmann A (2014)
The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival
Clin. Transplant., 28 (1), 120-126
DOI 10.1111/ctr.12288

Publications 2013

Asberg A, Apeland T, Reisaeter AV, Foss A, Leivestad T, Heldal K, Thorud LO, Eriksen BO, Hartmann A, NILS Study Grp (2013)
Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation results from an aborted trial
Clin. Transplant., 27 (2), E151-E156
DOI 10.1111/ctr.12076

Asberg A, Midtvedt K, van Guilder M, Storset E, Bremer S, Bergan S, Jelliffe R, Hartmann A, Neely MN (2013)
Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation
Transpl. Int., 26 (12), 1198-1207
DOI 10.1111/tri.12194

Dahle DO, Midtvedt K, Hartmann A, Jenssen T, Holdaas H, Mjoen G, Leivestad T, Asberg A (2013)
Endothelial Dysfunction Is Associated With Graft Loss in Renal Transplant Recipients
Transplantation, 95 (5), 733-739
DOI 10.1097/TP.0b013e31827d6312

Dorje C, Midtvedt K, Holdaas H, Naper C, Strom EH, Oyen O, Leivestad T, Aronsen T, Jenssen T, Flaa-Johnsen L, Lindahl JP, Hartmann A, Reisaeter AV (2013)
Early Versus Late Acute Antibody-Mediated Rejection in Renal Transplant Recipients
Transplantation, 96 (1), 79-84
DOI 10.1097/TP.0b013e31829434d4

Flechner SM, Gurkan A, Hartmann A, Legendre CM, Russ GR, Campistol JM, Schena FP, Hahn CM, Li HH, Korth-Bradley JM, Tai SS, Schulman SL (2013)
A Randomized, Open-Label Study of Sirolimus Versus Cyclosporine in Primary De Novo Renal Allograft Recipients
Transplantation, 95 (10), 1233-1241
DOI 10.1097/TP.0b013e318291a269

Heldal K, Thorarinsdottir S, Hartmann A, Leivestad T, Reisaeter AV, Foss AE, Midtvedt K (2013)
Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study
Transplant. Res., 2, 11
DOI 10.1186/2047-1440-2-11

Holme I, Fellstrom BC, Jardine AG, Hartmann A, Holdaas H (2013)
Model Comparisons of Competing Risk and Recurrent Events for Graft Failure in Renal Transplant Recipients
Clin. J. Am. Soc. Nephrol., 8 (2), 241-247
DOI 10.2215/CJN.03760412

Rollag H, Ueland T, Asberg A, Hartmann A, Jardine AG, Humar A, Pescovitz MD, Bignamini AA, Aukrust P (2013)
Characterization of Cytomegalovirus Disease in Solid Organ Transplant Recipients by Markers of Inflammation in Plasma
PLoS One, 8 (4), e60767
DOI 10.1371/journal.pone.0060767

Publications 2012

Bleskestad IH, Bergrem H, Hartmann A, Godang K, Goransson LG (2012)
Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial
BMC Nephrol., 13, 49
DOI 10.1186/1471-2369-13-49

Emery VC, Manuel O, Asberg A, Pang XL, Kumar D, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Gahlemann CG, Humar A (2012)
Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy
J. Clin. Virol., 54 (1), 56-60
DOI 10.1016/j.jcv.2012.01.015

Hartmann A, Jenssen T, Holdaas H (2012)
Diabetes, chronic kidney disease and cancer risk
Nephrol. Dial. Transplant., 27 (8), 3018-3020
DOI 10.1093/ndt/gfs175

Loftheim H, Midtvedt K, Hartmann A, Reister AV, Falck P, Holdaas H, Jenssen T, Reubsaet L, Asberg A (2012)
Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients
Transplant. Res., 1, 9
DOI 10.1186/2047-1440-1-9

Mjoen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2012)
Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
Nephrol. Dial. Transplant., 27 (1), 443-447
DOI 10.1093/ndt/gfr303

Rollag H, Asberg A, Ueland T, Hartmann A, Jardine AG, Humar A, Pescovitz MD, Bignamini AA, Aukrust P (2012)
Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: Markers of Inflammation as Predictors of Outcome
Transplantation, 94 (10), 1060-1065
DOI 10.1097/TP.0b013e31826c39de

Valderhaug TG, Hjelmesaeth J, Jenssen T, Roislien J, Leivestad T, Hartmann A (2012)
Early Posttransplantation Hyperglycemia in Kidney Transplant Recipients Is Associated With Overall Long-term Graft Losses
Transplantation, 94 (7), 714-720
DOI 10.1097/TP.0b013e31825f4434

Publications 2011

Bjorneklett R, Vikse BE, Smerud HK, Bostad L, Leivestad T, Hartmann A, Iversen BM (2011)
Pre-transplant course and risk of kidney transplant failure in IgA nephropathy patients
Clin. Transplant., 25 (3), E356-E365
DOI 10.1111/j.1399-0012.2011.01424.x

Heldal K, Hartmann A, Leivestad T, Foss A, Midtvedt K (2011)
Risk variables associated with the outcome of kidney recipients > 70 years of age in the new millennium
Nephrol. Dial. Transplant., 26 (8), 2706-2711
DOI 10.1093/ndt/gfq786

Jenssen T, Hartmann A (2011)
Prevention and management of transplant-associated diabetes
Expert Opin. Pharmacother., 12 (17), 2641-2655
DOI 10.1517/14656566.2011.628936

Lisboa LF, Asberg A, Kumar D, Pang XL, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Humar A (2011)
The Clinical Utility of Whole Blood Versus Plasma Cytomegalovirus Viral Load Assays for Monitoring Therapeutic Response
Transplantation, 91 (2), 231-236
DOI 10.1097/TP.0b013e3181ff8719

Midtvedt K, Jenssen T, Hartmann A, Vethe NT, Bergan S, Havnes K, Asberg A (2011)
No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus
Nephrol. Dial. Transplant., 26 (11), 3767-3772
DOI 10.1093/ndt/gfr153

Myhre HA, Dorenberg DH, Kristiansen KI, Rollag H, Leivestad T, Asberg A, Hartmann A (2011)
Incidence and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infections in 1244 Kidney Transplant Recipients
Transplantation, 92 (2), 217-223
DOI 10.1097/TP.0b013e31821fad25

Norby GE, Gunther A, Mjoen G, Andersen R, Dolgos S, Hartmann A, Holdaas H (2011)
Prevalence and risk factors for coronary artery calcification following kidney transplantation for systemic lupus erythematosus
RHEUMATOLOGY, 50 (9), 1659-1664
DOI 10.1093/rheumatology/ker186

Norby GE, Leivestad T, Mjoen G, Hartmann A, Midtvedt K, Gran JT, Holdaas H (2011)
Premature Cardiovascular Disease in Patients With Systemic Lupus Erythematosus Influences Survival After Renal Transplantation
Arthritis Rheum., 63 (3), 733-737
DOI 10.1002/art.30184

Sagedal S, Witczak BJ, Osnes K, Hartmann A, Os I, Eikvar L, Klingenberg O, Brosstad F (2011)
A Heparin-Coated Dialysis Filter (AN69 ST) Does Not Reduce Clotting during Hemodialysis when Compared to a Conventional Polysulfone Filter (F x 8)
Blood Purif., 32 (3), 151-155
DOI 10.1159/000325227

Syversveen T, Brabrand K, Midtvedt K, Strom EH, Hartmann A, Berstad AE (2011)
Non-invasive assessment of renal allograft fibrosis by dynamic sonographic tissue perfusion measurement
Acta Radiol., 52 (8), 920-926
DOI 10.1258/ar.2011.110215

Syversveen T, Brabrand K, Midtvedt K, Strom EH, Hartmann A, Jakobsen JA, Berstad AE (2011)
Assessment of renal allograft fibrosis by acoustic radiation force impulse quantification - a pilot study
Transpl. Int., 24 (1), 100-105
DOI 10.1111/j.1432-2277.2010.01165.x

Publications 2010

Asberg A, Falck P, Undset LH, Dorje C, Holdaas H, Hartmann A, Midtvedt K (2010)
Computer-Assisted Cyclosporine Dosing Performs Better Than Traditional Dosing in Renal Transplant Recipients: Results of a Pilot Study
Ther. Drug Monit., 32 (2), 152-158
DOI 10.1097/FTD.0b013e3181d3f822

Asberg A, Rollag H, Hartmann A (2010)
Valganciclovir for the prevention and treatment of CMV in solid organ transplant recipients
Expert Opin. Pharmacother., 11 (7), 1159-1166
DOI 10.1517/14656561003742954

Bergrem HA, Valderhaug TG, Hartmann A, Bergrem H, Hjelmesaeth J, Jenssen T (2010)
Glucose tolerance before and after renal transplantation
Nephrol. Dial. Transplant., 25 (3), 985-992
DOI 10.1093/ndt/gfp566

Bergrem HA, Valderhaug TG, Hartmann A, Hjelmesaeth J, Leivestad T, Bergrem H, Jenssen T (2010)
Undiagnosed Diabetes in Kidney Transplant Candidates: A Case-Finding Strategy
Clin. J. Am. Soc. Nephrol., 5 (4), 616-622
DOI 10.2215/CJN.07501009

Dolgos S, Hartmann A, Isaksen GA, Simonsen S, Bjortuft O, Boberg KM, Bollerslev J (2010)
Osteoporosis is a prevalent finding in patients with solid organ failure awaiting transplantation - a population based study
Clin. Transplant., 24 (5), E145-E152
DOI 10.1111/j.1399-0012.2010.01231.x

Elgstoen KBP, Johnsen LF, Woldseth B, Morkrid L, Hartmann A (2010)
Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria
Nephrol. Dial. Transplant., 25 (7), 2341-2345
DOI 10.1093/ndt/gfq065

Gude E, Andreassen AK, Arora S, Gullestad L, Grov I, Hartmann A, Leivestad T, Fiane AE, Geiran OR, Vardal M, Simonsen S (2010)
Acute renal failure early after heart transplantation: risk factors and clinical consequences
Clin. Transplant., 24 (6), E207-E213
DOI 10.1111/j.1399-0012.2010.01225.x

Gude E, Gullestad L, Arora S, Simonsen S, Hoel I, Hartmann A, Holdaas H, Fiane AE, Geiran OR, Andreassen AK (2010)
Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation
J. Heart Lung Transplant., 29 (6), 641-647
DOI 10.1016/j.healun.2010.01.005

Heldal K, Hartmann A, Grootendorst DC, de Jager DJ, Leivestad T, Foss A, Midtvedt K (2010)
Benefit of kidney transplantation beyond 70 years of age
Nephrol. Dial. Transplant., 25 (5), 1680-1687
DOI 10.1093/ndt/gfp681

Hirsch HH, Hartmann A (2010)
Immunotherapy for Invasive Fungal Infections in Transplant Patients: Back to the Future?
Am. J. Transplant., 10 (8), 1719-1720
DOI 10.1111/j.1600-6143.2010.03189.x

Hjelmesaeth J, Roislien J, Nordstrand N, Hofso D, Hager H, Hartmann A (2010)
Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: a cross-sectional study
BMC Endocr. Disord., 10, 6
DOI 10.1186/1472-6823-10-6

Norby GE, Strom EH, Midtvedt K, Hartmann A, Gilboe IM, Leivestad T, Stenstrom J, Holdaas H (2010)
Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study
Ann. Rheum. Dis., 69 (8), 1484-1487
DOI 10.1136/ard.2009.122796

Aasebo W, Midtvedt K, Valderhaug TG, Leivestad T, Hartmann A, Reisaeter AV, Jenssen T, Holdaas H (2010)
Impaired glucose homeostasis in renal transplant recipients receiving basiliximab
Nephrol. Dial. Transplant., 25 (4), 1289-1293
DOI 10.1093/ndt/gfp617

Publications 2009

Amundsen R, Asberg A, Robertsen I, Vethe NT, Bergan S, Hartmann A, Midtvedt K (2009)
Rimonabant Affects Cyclosporine A, but Not Tacrolimus Pharmacokinetics in Renal Transplant Recipients
Transplantation, 87 (8), 1221-1224
DOI 10.1097/TP.0b013e31819f1001

Asberg A, Midtvedt K, Voytovich MH, Line PD, Narverud J, Reisaeter AV, Morkrid L, Jenssen T, Hartmann A (2009)
Calcineurin inhibitor effects on glucose metabolism and endothelial function following renal transplantation
Clin. Transplant., 23 (4), 511-518
DOI 10.1111/j.1399-0012.2009.00962.x

Falck P, Midtvedt K, Van Le TT, Storehagen L, Holdaas H, Hartmann A, Asberg A (2009)
A Population Pharmacokinetic Model of Ciclosporin Applicable for Assisting Dose Management of Kidney Transplant Recipients
Clin. Pharmacokinet., 48 (9), 615-623
DOI 10.2165/11313380-000000000-00000

Hartmann A (2009)
Inn i det ukjente: en studie av nye trafikanters møte med Oslos kollektivtrafikk
In Rapport, Vegdirektoratet, Utbyggingsavdelingen, Oslo, nr. 2009/07, 96 s.
BIBSYS 093510403

Heldal K, Hartmann A, Leivestad T, Svendsen MV, Foss A, Lien B, Midtvedt K (2009)
Clinical Outcomes in Elderly Kidney Transplant Recipients are Related to Acute Rejection Episodes Rather Than Pretransplant Comorbidity
Transplantation, 87 (7), 1045-1051
DOI 10.1097/TP.0b013e31819cdddd

Manuel O, Asberg A, Pang XL, Rollag H, Emery VC, Preiksaitis JK, Kumar D, Pescovitz MD, Bignamini AA, Hartmann A, Jardine AG, Humar A (2009)
Impact of Genetic Polymorphisms in Cytomegalovirus Glycoprotein B on Outcomes in Solid-Organ Transplant Recipients with Cytomegalovirus Disease
Clin. Infect. Dis., 49 (8), 1160-1166
DOI 10.1086/605633

Valderhaug TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, Hjelmesaeth J (2009)
Fasting Plasma Glucose and Glycosylated Hemoglobin in the Screening for Diabetes Mellitus After Renal Transplantation
Transplantation, 88 (3), 429-434
DOI 10.1097/TP.0b013e3181af1f53

Witczak BJ, Leivestad T, Line PD, Holdaas H, Reisaeter AV, Jenssen TG, Midtvedt K, Bitter J, Hartmann A (2009)
Experience From an Active Preemptive Kidney Transplantation Program-809 Cases Revisited
Transplantation, 88 (5), 672-677
DOI 10.1097/TP.0b013e3181b27b7e

Aasebo W, Hartmann A, Jenssen T (2009)
Predictors of anemia in patients on hemodialysis
Hemodial. Int., 13 (3), 335-339
DOI 10.1111/j.1542-4758.2009.00376.x

Aasebo W, Homb-Vesteraas NA, Hartmann A, Stavem K (2009)
Life situation and quality of life in young adult kidney transplant recipients
Nephrol. Dial. Transplant., 24 (1), 304-308
DOI 10.1093/ndt/gfn537

Publications 2008

Apeland T, Hartmann A (2008)
Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation
Nephrol. Dial. Transplant., 23 (6), 2091-2094
DOI 10.1093/ndt/gfn099

Bergrem HA, Bergrem H, Hartmann A, Hjelmesaeth J, Jenssen T (2008)
Role of prednisolone pharmacokinetics in postchallenge glycemia after renal transplantation
Ther. Drug Monit., 30 (5), 583-590
DOI 10.1097/FTD.0b013e318187bb2f

Dolgos S, Hartmann A, Bonsnes S, Ueland T, Isaksen GA, Godang K, Pfeffer P, Bollerslev J (2008)
Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation
Clin. Transplant., 22 (4), 462-468
DOI 10.1111/j.1399-0012.2008.00810.x

Falck P, Asberg A, Guldseth H, Bremer S, Akhlaghi F, Reubsaet JLE, Pfeffer P, Hartmann A, Midtvedt K (2008)
Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients
Transplantation, 85 (2), 179-184
DOI 10.1097/TP.0b013e31815feede

Foss A, Gunther A, Line PD, Brabrand K, Holdaas H, Hartmann A, Midtvedt K (2008)
Long-term clinical outcome of paediatric kidneys transplanted to adults
Nephrol. Dial. Transplant., 23 (2), 726-729
DOI 10.1093/ndt/gfm826

Gunther A, Foss A, Holdaas H, Brabrand K, Hartmann A, Line PD, Midtvedt K (2008)
Increased peak systolic velocity in the renal artery of paediatric kidneys transplanted to adult recipients
Nephrol. Dial. Transplant., 23 (12), 4041-4043
DOI 10.1093/ndt/gfn358

Hartmann A, Jenssen T, Julsrud J (2008)
Nyremedisin: en praktisk veileder
Gyldendal akademisk, Oslo (2. utg.), 268 s.
BIBSYS 080553427, ISBN 978-82-05-38486-6

Heldal K, Leivestad T, Hartmann A, Svendsen MV, Lien BH, Midtvedt K (2008)
Kidney transplantation in the elderly - the Norwegian experience
Nephrol. Dial. Transplant., 23 (3), 1026-1031
DOI 10.1093/ndt/gfm719

Hesselink DA, van Schaik RHN, van Agteren M, de Fijter JW, Hartmann A, Zeier M, Budde K, Kuypers DRJ, Pisarski P, Le Meur Y, Mamelok RD, van Gelder T (2008)
CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients
Pharmacogenet. Genomics, 18 (4), 339-348
DOI 10.1097/FPC.0b013e3282f75f88

Sagedal S, Thiel S, Hansen TK, Mollnes TE, Rollag H, Hartmann A (2008)
Impact of the complement lectin pathway on cytomegalovirus disease early after kidney transplantation
Nephrol. Dial. Transplant., 23 (12), 4054-4060
DOI 10.1093/ndt/gfn355

van Agteren M, Armstrong VW, van Schaik RHN, de Fijter H, Hartmann A, Zeier M, Budde K, Kuypers D, Pisarski P, Le Meur Y, van der Werf M, Mamelok RD, Oellerich M, van Gelder T (2008)
AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G > A gene polymorphism
Ther. Drug Monit., 30 (4), 439-444

van Gelder T, Silva HT, de Fijter JW, Budde K, Kuypers D, Tyden G, Lohmus A, Sommerer C, Hartmann A, Le Meur Y, Oellerich M, Holt DW, Tonshoff B, Keown P, Campbell S, Mamelok RD (2008)
Comparing Mycophenolate Mofetil Regimens for de Novo Renal Transplant Recipients: The Fixed-Dose Concentration-Controlled Trial
Transplantation, 86 (8), 1043-1051
DOI 10.1097/TP.0b013e318186f98a

Publications 2007

Foss A, Line PD, Brabrand K, Midtvedt K, Hartmann A (2007)
A prospective study on size and function of paediatric kidneys (< 10 years) transplanted to adults
Nephrol. Dial. Transplant., 22 (6), 1738-1742
DOI 10.1093/ndt/gfm080

Hielmesaeth J, Jenssen T, Hartmann A (2007)
Ghrelin, atherosclerosis, and glucose: GAG or causal relationships?
Transplantation, 84 (10), 1220-1221
DOI 10.1097/01.tp.0000287429.29273.ca

Hjelmesaeth J, Asberg A, Hartmann A, Jenssen T (2007)
The effect of ciclosporin on insulin secretion and resistance - Reply
Nephrol. Dial. Transplant., 22 (11), 3359
DOI 10.1093/ndt/gfm526

Hjelmesaeth J, Hagen LT, Asberg A, Midtvedt K, Storset O, Halvorsen CE, Morkrid L, Hartmann A, Jenssen T (2007)
The impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man
Nephrol. Dial. Transplant., 22 (6), 1743-1749
DOI 10.1093/ndt/gfl820

Sagedal S, Rollag H, Hartmann A (2007)
Cytomegalovirus infection in renal transplant recipients is associated with impaired survival irrespective of expected mortality risk
Clin. Transplant., 21 (3), 309-313
DOI 10.1111/j.1399-0012.2006.00639.x

Valderhaug TG, Hjelmesaeth J, Rollag H, Leivestad T, Roislien J, Jenssen T, Hartmann A (2007)
Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade
Transplantation, 84 (9), 1125-1130
DOI 10.1097/01.tp.0000287191.45032.38

Voytovich MH, Haukereid C, Hjelmesaeth J, Hartmann A, Lovik A, Jenssen T (2007)
Nateglinide improves postprandial hyperglycemia and insulin secretion in renal transplant recipients
Clin. Transplant., 21 (2), 246-251
DOI 10.1111/j.1399-0012.2006.00634.x

Witczak BJ, Jenssen T, Endresen K, Rolshen J, Hartmann A (2007)
Risk factors for, mortality in diabetic nephropathy patients accepted for transplantation
Transplantation, 84 (3), 356-361
DOI 10.1097/01.tp.0000276935.31584.4c

Publications 2006

Asberg A, Midtvedt K, Line PD, Narverud J, Holdaas H, Jenssen T, Reisaeter AV, Johnsen LF, Fauchald P, Hartmann A (2006)
Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients
Transplantation, 82 (1), 62-68
DOI 10.1097/01.tp.0000225803.04995.2b

Hartmann A, Sagedal S, Hjelmesaeth J (2006)
The natural course of cytomegalovirus infection and disease in renal transplant recipients
Transplantation, 82 (2 S), S15-S17
DOI 10.1097/01.tp.0000230460.42558.b0

Hjelmesaeth J, Flyvbjerg A, Jenssen T, Frystyk J, Ueland T, Hagen M, Hartmann A (2006)
Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation: Impact of immunosuppressive and antihypertensive drug therapy
Clin. J. Am. Soc. Nephrol., 1 (3), 575-582
DOI 10.2215/CJN.01471005

Hjelmesaeth J, Ueland T, Flyvbjerg A, Bollerslev J, Leivestad T, Jenssen T, Hansen TK, Thiel S, Sagedal S, Roislien J, Hartmann A (2006)
Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients
J. Am. Soc. Nephrol., 17 (6), 1746-1754
DOI 10.1681/ASN.2005121368

Publications 2005

Hjelmesth J, Asberg A, Muller F, Hartmann A, Jenssen T (2005)
New-Onset Posttransplantation Diabetes Mellitus: Insulin Resistance or Insulinopenia? Impact of Immunosuppressive Drugs, Cytomegalovirus and Hepatitis C Virus Infection
Curr. Diabetes Reviews, 1 (1), 1-10
DOI 10.2174/1573399052952604

Publications 2004

Hartmann A, Jenssen T (2004)
Nyremedisin: en praktisk veileder
Gyldendal akademisk, Oslo, 215 s.
BIBSYS 040099555, ISBN 82-05-32555-3

Publications 1987

Hartmann A (1987)
Biocarbonate-dependent solute transport in kidney tubules
Institute for Experimental Medical Research, University of Oslo, Ullevål Hospital, Oslo, 1 b. (flere pag.)
BIBSYS 875012639, ISBN 82-90246-19-6